Investing Profile

Reinhard Ambros

Angel
Head Novartis Venture Funds at Novartis Venture Fund
Basel, Switzerland
Photo of Reinhard Ambros, Novartis Venture Fund

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of Illinois Urbana-Champaign Network
142 CONNECTIONS
Novartis Network
71 CONNECTIONS
Novartis Network
71 CONNECTIONS
Novartis Network
71 CONNECTIONS
Roche Network
46 CONNECTIONS
cb
$5K - $50K
$25K
10
$750M
CompanyStageDateRound SizeTotal Raised
ImmunOs Therapeutics
Series ADec 2019$15M
$99M
Co-investors: Miklos Stanek (BackBone Ventures), Michael Baran (Pfizer Venture Investments), Marcos Milla (Samsara BioCapital), Daniel Vasella (Numab Therapeutics AG)
Rein Therapeutics
Series EOct 2014$33M
Series ENov 2013$30M
Series DJan 2013$12M
Series DJun 2009$40M
Series CApr 2008$11M
Series BJun 2007$7M
$130M
Co-investors: Seth L. Harrison (ATP (Apple Tree Partners)), Brian Gallagher (SR One Capital Management)
FORMA Therapeutics
Series BDec 2009$3M
Series BDec 2009$26M
Series AApr 2008$4M
$130M
Co-investors: Peter Kolchinsky (RA Capital)
Global Project Leader RochePresent
Head BD&L for Cardiovascular and Metabolism NovartisPresent
Head Novartis Group Strategy NovartisPresent
Head Novartis Venture Funds NovartisPresent
Board Of Directors GenedataPresent
Board Of Directors Rein TherapeuticsPresent
Board Of Directors ARTIDISPresent
Board Of Directors ViridosPresent
Chairman of the Board of Directors ImmunOs Therapeutics AGPresent
Board Of Directors TruDataRxPresent
Chairman Of The Board Versameb AGPresent
Chairman of the Board of Directors TOLREMO therapeuticsPresent
Head Novartis Venture Funds Novartis Venture Fund2005 - 2018
University of Regensburg Doctor of Philosophy (Ph.D.) Medicinal and Pharmaceutical Chemistry
University of Illinois Urbana-Champaign post Doc Chemistry
University of Kentucky College of Medicine post Doc Pharmacology, Pharmcokinetics, Pharmcodynamics
Sign in with Google →
Sign in with Google →